NRx Pharmaceuticals Receives FDA Approval of Preservative-Free Ketamine, to Be Made in West Columbia

November 2, 2026 Luer-lock vials on a production line, with the NRx Pharmaceuticals and Nephron logos side by side.

On October 30, 2026, our partners at NRx Pharmaceuticals announced FDA approval of their preservative-free ketamine. The product will be manufactured with Nephron at our campus in West Columbia, South Carolina.

From NRx’s announcement:

“NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) … today announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s Abbreviated New Drug Application (ANDA) for Preservative-Free Ketamine.”

“We are pleased to work with our partners at Nephron Pharmaceuticals in West Columbia, South Carolina, who have helped us prove that sterile, preservative-free injectables can be made in America.” – Jonathan Javitt, MD, MPH, Chairman and CEO, NRx Pharmaceuticals

Congratulations to the NRx team. We’re proud to be part of this work.

Read NRx’s full release: https://ir.nrxpharma.com/news-releases/news-release-details/nrx-pharmaceuticals-nasdaqnrxp-receives-fda-approval